Prospect Capital REIT Invests $46 Million in Diverse Student Housing Portfolio
Oct 04, 2016 11:01 am UTC| Business
NEW YORK, Oct. 04, 2016 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that a Prospect portfolio company, together with a co-investor, invested a combined total of approximately $72 million...
LKQ Corporation Acquires Andrew Page Limited
Oct 04, 2016 11:01 am UTC| Business
CHICAGO, Oct. 04, 2016 -- LKQ Corporation (Nasdaq:LKQ) today announced that its United Kingdom subsidiary, Euro Car Parts, has acquired substantially all the business assets of Andrew Page Limited, a distributor of...
LKQ Corporation Acquires Andrew Page Limited
Oct 04, 2016 11:01 am UTC| Business
CHICAGO, Oct. 04, 2016 -- LKQ Corporation (Nasdaq:LKQ) today announced that its United Kingdom subsidiary, Euro Car Parts, has acquired substantially all the business assets of Andrew Page Limited, a distributor of...
Akoustis™ Chief Materials Scientist to Present at IWN 2016
Oct 04, 2016 11:01 am UTC| Business
Charlotte, N.C., Oct. 04, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of innovative BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile wireless,...
Akoustis™ Chief Materials Scientist to Present at IWN 2016
Oct 04, 2016 11:01 am UTC| Business
Charlotte, N.C., Oct. 04, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of innovative BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile wireless,...
AGTC to Present at Upcoming Scientific Conferences
Oct 04, 2016 11:01 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 04, 2016 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for...
AGTC to Present at Upcoming Scientific Conferences
Oct 04, 2016 11:01 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 04, 2016 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for...